Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial

PURPOSE: To explore the potential correlation between baseline interleukin (IL) values and overall survival or objective response in patients with hepatocellular carcinoma (HCC) receiving sorafenib. METHODS: A subset of patients with HCC undergoing sorafenib monotherapy within a prospective multicen...

Descripción completa

Detalles Bibliográficos
Autores principales: Öcal, Osman, Schütte, Kerstin, Kupčinskas, Juozas, Morkunas, Egidijus, Jurkeviciute, Gabija, de Toni, Enrico N., Ben Khaled, Najib, Berg, Thomas, Malfertheiner, Peter, Klümpen, Heinz Josef, Sengel, Christian, Basu, Bristi, Valle, Juan W., Benckert, Julia, Gasbarrini, Antonio, Palmer, Daniel, Seidensticker, Ricarda, Wildgruber, Moritz, Sangro, Bruno, Pech, Maciej, Ricke, Jens, Seidensticker, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800931/
https://www.ncbi.nlm.nih.gov/pubmed/33855585
http://dx.doi.org/10.1007/s00432-021-03627-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800931/
https://www.ncbi.nlm.nih.gov/pubmed/33855585
http://dx.doi.org/10.1007/s00432-021-03627-1

Ejemplares similares